Melanoma

IMM-101, an immunotherapeutic agent in clinical development as an adjunctive treatment for pancreatic cancer
Hilary Bilyard, Charlotte Mines, Laura Rosa Brunet, Angus Dalgleish, Frances Macintosh

Journal for ImmunoTherapy of Cancer Dec 2014, 2 (Suppl 3) P83; DOI: 10.1186/2051-1426-2-S3-P83
Expression of indoleamine 2.3-dioxygenase by tumors induces local and systemic immunosuppressive effects in a murine melanoma model
Rikke B Holmgaard, Dmitriy Zamarin, David H Munn, Taha Merghoub, Jedd D Wolchok

Journal for ImmunoTherapy of Cancer Dec 2014, 2 (Suppl 3) P212; DOI: 10.1186/2051-1426-2-S3-P212
A pilot study of Ipilimumab in patients with stage IV melanoma receiving palliative radiation therapy
Susan Knox, Sunil Reddy, Susan M Hiniker, Susan Swetter, Lei Shura, Holden T Maecker

Journal for ImmunoTherapy of Cancer Dec 2014, 2 (Suppl 3) P75; DOI: 10.1186/2051-1426-2-S3-P75
A heat-killed preparation of mycobacterium obuense can reduce metastatic burden in vivo
Daniel Fowler, Angus Dalgleish, Wai Liu

Journal for ImmunoTherapy of Cancer Dec 2014, 2 (Suppl 3) P54; DOI: 10.1186/2051-1426-2-S3-P54
T cell therapy in combination with Vemurafenib in BRAF mutated metastatic melanoma patients
Troels Holz Borch, Rikke Andersen, Per Kongsted, Özcan Met, Mads Hald Andersen, Per thor Straten, Marco Donia, Inge Marie Svane

Journal for ImmunoTherapy of Cancer Dec 2014, 2 (Suppl 3) P67; DOI: 10.1186/2051-1426-2-S3-P67
TLR2/6 agonists and IFN-gamma treatment induces favorable immune cell recruiting signatures from melanoma associated with STAT1 and IL-32 signaling
Ileana S Mauldin, Craig L Slingluff, Ena Wang

Journal for ImmunoTherapy of Cancer Dec 2014, 2 (Suppl 3) P225; DOI: 10.1186/2051-1426-2-S3-P225
Pilot trial of a type I - polarized autologous dendritic cell vaccine incorporating tumor blood vessel antigen-derived peptides in patients with metastatic breast cancer
Joseph Baar, Walter J Storkus, James Finke, Lisa Butterfield, Hillard Lazarus, Jane Reese, Katharine Downes, Thomas Budd, Adam Brufsky, Pingfu Fu

Journal for ImmunoTherapy of Cancer Dec 2015, 3 (Suppl 1) P3; DOI: 10.1186/2051-1426-3-S1-P3
CTLA-4 checkpoint blockade in breast cancer, a case in point report
Chiara Dellepiane, Michela Lia, Mario Roberto Sertoli

Journal for ImmunoTherapy of Cancer Dec 2015, 3 (Suppl 1) O4; DOI: 10.1186/2051-1426-3-S1-O4
PreImplantation factor (PIF) potentiates static magnetic field (SMF) effect to decrease tumor burden (melanoma murine model)
Beatrix Kotlan, Janos F Laszlo, Jozsef Tovari, Miklos Kasler, Eytan Barnea

Journal for ImmunoTherapy of Cancer Nov 2013, 1 (Suppl 1) P80; DOI: 10.1186/2051-1426-1-S1-P80
“First AID” for T cell adoptive transfer: TCR affinity maturation by somatic hypermutation
Yosi M Gozlan, Esther Tzehoval, Lea Eisenbach

Journal for ImmunoTherapy of Cancer Nov 2013, 1 (Suppl 1) P11; DOI: 10.1186/2051-1426-1-S1-P11

Main menu

Melanoma

Pages

Log in using your username and password

Main menu

Log in using your username and password

You are here

Melanoma

Pages